Sankalp Labs is transforming infection diagnostics for bone marrow transplant patients with rapid PCR tests targeting antimicrobial resistance (AMR). These tests detect pathogens within hours, enabling faster, targeted treatments and reducing unnecessary antibiotic use.
In the last quarter of 2024, thalassemia prevention coordinators from across India took part in a series of valuable training sessions. In Maharashtra, the focus was on building confidence, with role-playing exercises that helped coordinators improve their counseling skills.
Twelve years ago, a dream was born to save lives by freezing Bombay blood group units, extending their shelf life from 42 days to 10 years. Despite countless challenges and setbacks, the team at Sankalp Blood Center never gave up. In November 2023, their relentless dedication resulted in the first successful transfusion of a frozen red blood cell.
This heartwarming achievement ensures that patients with rare blood types now have hope, marking a life-saving breakthrough driven by passion, perseverance, and the commitment to making a difference.
As we enter 2025, we reaffirm our commitment to a thalassemia- and sickle-free India, where no one suffers from blood disorders. This year, we are embracing transformative changes to strengthen, refine, and scale the prevention, management, and cure models we’ve developed over the past 14 years. Our focus is on amplifying impact and advancing our mission for the greater societal good.
